| A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder LJ Robinson, JM Thompson, P Gallagher, U Goswami, AH Young, ... Journal of affective disorders 93 (1-3), 105-115, 2006 | 1184 | 2006 |
| Neurocognitive impairment in drug-free patients with major depressive disorder RJ Porter, P Gallagher, JM Thompson, AH Young The British Journal of Psychiatry 182 (3), 214-220, 2003 | 760 | 2003 |
| Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta‐analysis C Bourne, Ö Aydemir, V Balanzá‐Martínez, E Bora, S Brissos, ... Acta Psychiatrica Scandinavica 128 (3), 149-162, 2013 | 655 | 2013 |
| Neurocognitive impairment in euthymic patients with bipolar affective disorder JM Thompson, P Gallagher, JH Hughes, S Watson, JM Gray, IN Ferrier, ... The British Journal of Psychiatry 186 (1), 32-40, 2005 | 545 | 2005 |
| Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder S Watson, P Gallagher, JC Ritchie, IN Ferrier, AH Young The British Journal of Psychiatry 184 (6), 496-502, 2004 | 412 | 2004 |
| Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder AH Young, P Gallagher, S Watson, D Del-Estal, BM Owen, I Nicol Ferrier Neuropsychopharmacology 29 (8), 1538-1545, 2004 | 360 | 2004 |
| Neuropsychological impairment in major depression: its nature, origin and clinical significance RJ Porter, C Bourke, P Gallagher Australian & New Zealand Journal of Psychiatry 41 (2), 115-128, 2007 | 322 | 2007 |
| Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients AH Young, P Gallagher, RJ Porter American Journal of Psychiatry 159 (7), 1237-1239, 2002 | 271 | 2002 |
| Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder U Goswami, A Sharma, U Khastigir, IN Ferrier, AH Young, P Gallagher, ... The British Journal of Psychiatry 188 (4), 366-373, 2006 | 226 | 2006 |
| Corticosteroid-serotonin interactions in depression: a review of the human evidence RJ Porter, P Gallagher, S Watson, AH Young Psychopharmacology 173, 1-17, 2004 | 207 | 2004 |
| Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential CH Ashton, PB Moore, P Gallagher, AH Young Journal of Psychopharmacology 19 (3), 293-300, 2005 | 192 | 2005 |
| Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force KW Miskowiak, KE Burdick, A Martinez‐Aran, CM Bonnin, CR Bowie, ... Bipolar Disorders 19 (8), 614-626, 2017 | 173 | 2017 |
| A comparison of neurocognitive impairment in younger and older adults with major depression AJ Thomas, P Gallagher, LJ Robinson, RJ Porter, AH Young, IN Ferrier, ... Psychological Medicine 39 (5), 725-733, 2009 | 172 | 2009 |
| Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder P Gallagher, S Watson, MS Smith, AH Young, IN Ferrier Schizophrenia research 90 (1-3), 258-265, 2007 | 170 | 2007 |
| Assessing cortisol and dehydroepiandrosterone (DHEA) in saliva: effects of collection method P Gallagher, MM Leitch, AE Massey, RH McAllister-Williams, AH Young Journal of Psychopharmacology 20 (5), 643-649, 2006 | 155 | 2006 |
| Childhood trauma in bipolar disorder S Watson, P Gallagher, D Dougall, R Porter, J Moncrieff, IN Ferrier, ... Australian & New Zealand Journal of Psychiatry 48 (6), 564-570, 2014 | 154 | 2014 |
| Hypothalamic–pituitary–adrenal axis function in patients with chronic depression S Watson, P Gallagher, D Del-Estal, A Hearn, IN Ferrier, AH Young Psychological medicine 32 (6), 1021-1028, 2002 | 154 | 2002 |
| Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community P Mackin, D Bishop, H Watkinson, P Gallagher, IN Ferrier The British Journal of Psychiatry 191 (1), 23-29, 2007 | 148 | 2007 |
| Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians KW Miskowiak, KE Burdick, A Martinez‐Aran, CM Bonnin, CR Bowie, ... Bipolar disorders 20 (3), 184-194, 2018 | 141 | 2018 |
| Prevalence of cognitive impairment in major depression and bipolar disorder KM Douglas, P Gallagher, LJ Robinson, JD Carter, VVW McIntosh, ... Bipolar disorders 20 (3), 260-274, 2018 | 138 | 2018 |
Allan YoungKing's College LondonVerified email at kcl.ac.uk
